The Daily Pour on MSN
Q&A: Navigating compliance in the non-alc and functional beverage space with Rend Al-Mondhiry
Rend Al-Mondhiry is Partner and Co-Chair of the Regulatory Practice Group at Amin Wasserman Gurnani LLP. She advises dietary ...
By Sriparna Roy April 14 (Reuters) - The U.S. Food and Drug Administration has asked Eli Lilly for more data on liver injury ...
The Food and Drug Administration is asking Eli Lilly to gather more safety data on its new weight loss pill, Foundayo, ...
Monday’s FDA approval makes Filspari the first therapy specifically indicated for FSGS, a condition that represents a $1 ...
In the past 18 months, the FDA has outlined clear guidelines for designing, documenting, updating, and monitoring AI-powered ...
FDA moves shaping drug development and oversight include new gene therapy guidance, clinical trial transparency efforts, and recent drug approvals.
Kim Trautman, an industry expert, shares some practical tips and tools for companies to navigate FDA’s new inspection process ...
A drug long used to fight cancer may soon take on a very different role. Researchers at the University of Illinois Chicago ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results